Vanguard Group Inc Equillium, Inc. Put Options Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding EQ
# of Institutions
28Shares Held
11.3MCall Options Held
13.2KPut Options Held
100-
Decheng Capital LLC Menlo Park, CA4.45MShares$1.87 Million0.49% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC4.45MShares$1.87 Million1.82% of portfolio
-
Cota Capital Management, LLC San Francisco, CA562KShares$236,156100.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny270KShares$113,1900.0% of portfolio
-
Geode Capital Management, LLC Boston, MA205KShares$86,2540.0% of portfolio
About Equillium, Inc.
- Ticker EQ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,352,100
- Market Cap $14.4M
- Description
- Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...